PCI-PAL (PCIP) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
9 Oct, 2026Executive summary
FY24 revenue rose 20% to £17.96m, recurring revenue grew 24% to £16.06m, and exit ARR increased 23% to £15.45m.
Adjusted EBITDA reached £0.87m profit, the first full year of adjusted EBITDA profit since relaunch; operating cash flow was positive.
Customer retention was 97% and net revenue retention was 102%; the partner ecosystem expanded, including a global reseller agreement with Zoom.
Patent litigation was fully settled after successful UK court outcomes, removing a major distraction and cash drain.
Year-end cash was £4.33m, with access to an undrawn £3m credit facility.
Financial highlights
Revenue was £17.96m, up 20%; recurring revenue increased 24% to £16.06m, or 89% of total revenue.
Gross profit rose 22% to £16.02m; gross margin was 89.2%, up 160 bps from 87.6%.
Adjusted EBITDA was £0.87m profit versus a £1.11m loss; reported EBITDA loss narrowed to £0.28m from £3.70m.
Adjusted loss after tax narrowed to £0.08m from £2.64m; statutory loss before tax improved to £1.71m from £4.89m.
New ACV sales were £3.76m, down 10% YoY, while exit TACV rose 17% to £19.21m.
Outlook and guidance
Management expressed confidence in continued FY25 growth, supported by a strong pipeline and multi-year opportunity; FY25 Q1 new business ACV was on target and sales were in line with expectations.
Management expects TACV growth of 18%-20% over the next three years and aims to accelerate growth from a profitable base.
Further FY25 investment is planned, including sales and marketing, partner onboarding, customer time to value and product enhancements.
FY25 revenue comparisons are affected by deferred revenue recognition, with a double contribution in FY25; management advised looking beneath headline growth forecasts.
Plans include conversational AI partnerships, a voice/chat payment-bot API and internally developed AI products.
Latest events from PCI-PAL
- ARR up 27%, revenue ahead of forecasts, and US market momentum supports FY27 outlook.PCIP
H2 2026 TU - Record ARR growth and strong partner sales drive positive outlook despite lower EBITDA.PCIP
H1 2026 - ARR up 21% to £20.3m and revenue up 7%, with strong retention and US healthcare growth.PCIP
H1 2026 TU - Transforming into a secure engagement platform with strong growth, targeting GBP 50m revenue.PCIP
CMD 2025 - FY25 revenue rose 25% to £22.5m, with £0.8m adjusted PBT and new product opportunities.PCIP
H2 2025 - ARR up 25%, new AI product, and strong partnerships drive double-digit growth targets.PCIP
Trading Update - Revenue up 20% and new partnerships set the stage for further growth in FY25.PCIP
Trading Update - Revenue grew 26%, with record new-business sales and adjusted profitability.PCIP
H1 2025 - Record H1 new business and 21% ARR growth highlight PCI Pal's strong momentum.PCIP
Trading Update